CXCL10 and COVID-19: In COVID-19 patients, SARS-CoV-2 infection triggered excessive production of CXCL10, thereby resulting in over recruitment of inflammatory neutrophils, macrophages and Th1 lymphocytes into lung tissue which could cause pulmonary inflammation and destruction (32, 33).